Evidence map›Paper›PMID 35331321›Full record

ArticleItalian journal of pediatrics2022

Mutational analysis of compound heterozygous mutation p.Q6X/p.H232R in SRD5A2 causing 46,XY disorder of sex development.

Liwei Li, Junhong Zhang, Qing Li, Li Qiao, Pengcheng Li, Yi Cui, Shujun Li, Shirui Hao, Tongqian Wu, Lili Liu and 5 more

Open access · goldAbstract read
In one paragraph

Article in Italian journal of pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. [Value of the human chorionic gonadotropin stimulation test in the diagnosis of disorder of sexual development in children].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Liwei Li *The Clinical Laboratory, Xingtai People's Hospital, Xingtai, China.
Junhong Zhang *Department of Pathology, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Qing LiDepartment of Orthopaedics, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Li QiaoClinical Research Center, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Pengcheng LiDepartment of Burn and Plastic Surgery, the 8th medical center of Chinese PLA General Hospital, Beijing, China.
Yi CuiClinical Research Center, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Shujun LiThe Clinical Laboratory, Xingtai People's Hospital, Xingtai, China.
Shirui HaoThe Clinical Laboratory, Xingtai People's Hospital, Xingtai, China.
Tongqian WuClinical Research Center, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Lili LiuDepartment of Ultrasound, Xingtai People's Hospital, Xingtai, China.
Jianmin YinDepartment of Ultrasound, Xingtai People's Hospital, Xingtai, China.
Pingsheng HuClinical Research Center, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Xiaowei DouClinical Research Center, the Affiliated Hospital of Guizhou Medical University, Guiyang, China. douxw@gmc.edu.cn.
Shuping LiThe Clinical Laboratory, Xingtai People's Hospital, Xingtai, China. lilishuping01@163.com.
Hui YangClinical Research Center, the Affiliated Hospital of Guizhou Medical University, Guiyang, China. yhui@gmc.edu.cn.ORCID http://orcid.org/0000-0001-5060-787X
Guiyang Medical University · CNHebei Medical University · CNChinese PLA General Hospital · CN

Funding

National Natural Science Fund Cultivation Project of Guizhou Medical University 20NSP025Science and Technology Foundation of Guizhou Health Committee gzwjkj2019-1-036the National Natural Science Foundation of China No. 81860516Xingtai Science and Technology Bureau 2020ZC343
6 · The paper itself

Abstract

backgroundOver 100 mutations in the SRD5A2 gene have been identified in subjects with 46,XY disorder of sex development (DSD). Exploration of SRD5A2 mutations and elucidation of the molecular mechanisms behind their effects should reveal the functions of the domains of the 5α-reductase 2 enzyme and identify the cause of 46,XY DSD. Previously, we reported a novel compound heterozygous p.Q6X/p.H232R mutation of the SRD5A2 gene in a case with 46,XY DSD. Whether the compound heterozygous p.Q6X/p.H232R mutation in this gene causes 46,XY DSD requires further exploration.

methodsThe two 46,XY DSD cases were identified and sequenced. In order to identify the source of the compound heterozygous p.Q6X/p.H232R mutation, the parents, maternal grandparents, and maternal uncle were sequenced. Since p.Q6X mutation is a nonsense mutation, p.H232R mutation was transfected into HEK293 cells and dihydrotestosterone (DHT) production were analyzed by liquid chromatography-mass spectrometry (LC-MS) for 5α-reductase 2 enzyme activities test. Apparent michaelis constant (Km) were measured of p.H232R mutation to analyze the binding ability change of 5α-reductase 2 enzyme with testosterone (T) or NADPH.

resultsThe sequence results showed that the two 46,XY DSD cases were the compound heterozygous p.Q6X/p.H232R mutation, of which the heterozygous p.Q6X mutation originating from maternal family and heterozygous p.H232R mutation originating from the paternal family. The function analysis confirmed that p.H232R variant decreased the DHT production by LC-MS test. The Km analysis demonstrated that p.H232R mutation affected the binding of SRD5A2 with T or NADPH.

conclusionsOur findings confirmed that the compound heterozygous p.Q6X/p.H232R mutation in the SRD5A2 gene is the cause of 46,XY DSD. p.H232R mutation reduced DHT production while attenuating the catalytic efficiency of the 5α-reductase 2 enzyme.

Indexed as

DihydrotestosteroneSexual Development3-Oxo-5-alpha-Steroid 4-DehydrogenaseHEK293 CellsHeterozygoteHumansMembrane ProteinsMutation3-Oxo-5-alpha-Steroid 4-DehydrogenaseDihydrotestosteroneMembrane ProteinsSRD5A2 protein, human46,XY DSD5α-reductase 2 catalytic efficiencyDihydrotestosteronep.Q6X/p.H232R mutationSRD5A2

Identifiers

PMID35331321
PMCPMC8944008
OpenAlexW4225853652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.